Personalized and Predictive Insulin Dosing for the Healthcare Enterprise
Monarch Medical Technologies, the maker of the EndoTool® Glucose Management System, is the leading provider of precision insulin dosing technology for improved patient outcomes.
A True Precision Medicine Tool for Inpatient Glucose Management
Proven, patented algorithms to model, predict and adapt dosing recommendations to each patient and their individual response for more precise, safer inpatient insulin therapy.
Intravenous (IV) insulin dosing software to manage hyperglycemia while avoiding hypoglycemia
Basal-bolus subcutaneous insulin dosing software supporting industry guidelines and standards
Clinical Research & Case Studies
Demonstrated to Improve the Quality and Safety of Glucose Management
Learn MoreSpotlight
Check out the latest news and resources from the Monarch team and EndoTool users.
On Demand Webinar
It’s About Time! Reducing Hypoglycemia in the Inpatient Setting
This on demand webinar discusses the common causes for inpatient hypoglycemia, including the timing of blood glucose checks and insulin delivery, and initiatives that can be taken to reduce hypoglycemia.
Watch the WebinarArticle
2022 CMS Changes for Inpatient Diabetes Management
The 2022 final rule from CMS brings new Electronic Clinical Quality Measures for the management of in hospital diabetes. This rule will standardize reporting for inpatient hyperglycemia and inpatient hypoglycemia and directly impacts hospitals public rank.
Read MoreClinical Research
Use of a Computer-Guided Glucose Management System to Improve Glycemic Control and Address National Quality Measures
A retrospective observational study evaluated the 7-year impact of the EndoTool® eGMS in intensive and intermediate units at Vidant Medical Center, a 900-bed tertiary teaching hospital.
Read More